Sign in

CIK 0000907654

  • Non-accelerated filer
  • Smaller reporting company

Oruka Therapeutics, Inc.

Sign in to watch
Ticker
ORKA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
363855489
Phone
+1 650-606-7910
Business address
855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
Former names
ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
  1. 4 Planned sale Chief Medical Officer sold 7,000 shares at an average $61.85 ($432,935)
  2. 4 Planned sale Chief Operating Officer sold 5,000 shares at an average $63.88 ($319,384)
  3. 4 Planned sale Chief Medical Officer sold 7,000 shares at an average $66.12 ($462,830)
  4. 4 Open-market sale Chief Executive Officer sold 1,729 shares at $41.30 ($71,408)
  5. 4 Open-market sale Senior Vice President, Finance sold 395 shares at $41.30 ($16,314)
  6. 4 Open-market sale Chief Operating Officer sold 600 shares at $41.30 ($24,780)
  7. 4 Planned sale Chief Medical Officer sold 7,641 shares at an average $40.91 ($312,560)
  8. 4 Open-market sale General Counsel sold 733 shares at $41.30 ($30,273)
  9. 4 Planned sale Chief Operating Officer sold 5,000 shares at an average $33.56 ($167,822)
  10. 4 Planned sale Chief Medical Officer sold 7,000 shares at an average $32.37 ($226,559)
  11. 4 Grant or award Chief Medical Officer acquired 32,500 shares (grant or award)
  12. 4 Grant or award Chief Operating Officer acquired 32,500 shares (grant or award)
  13. 4 Grant or award SVP, Finance acquired 17,500 shares (grant or award)
  14. 4 Grant or award Chief Executive Officer acquired 76,700 shares (grant or award)
  15. 4 Grant or award General Counsel acquired 32,500 shares (grant or award)
  16. 4 Other acquisition Director acquired 116,483 shares (other)
  17. 4 Planned sale Chief Medical Officer sold 7,000 shares at an average $31.81 ($222,704)
  18. 4 Planned sale Chief Operating Officer sold 13,000 shares at an average $28.52 ($370,795)
  19. 4 Planned sale Chief Medical Officer sold 7,000 shares at an average $30.61 ($214,293)
  20. 4 Derivatives Options or other derivatives

Page 3 of 23 · 459 filings